The Global Retigabine Market was valued at US$ 45.6 Million in 2022 and is projected to reach US$ 78.3 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period (2022-2030). This growth is driven by the rising prevalence of epilepsy disorders, increasing demand for novel antiepileptic drugs, and expanding applications in neurological research.

As pharmaceutical innovation accelerates toward targeted epilepsy therapies, attention focuses on key manufacturers developing retigabine, a potassium channel opener used for treatment-resistant partial-onset seizures. This analysis profiles the Top 10 Companies in the Retigabine Market—a combination of pharmaceutical leaders and specialized chemical innovators shaping the future of neurological therapeutics.

---

🔟 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Retigabine API & Research-grade Compounds

Merck’s life science division is a global leader in retigabine supply for pharmaceutical development and academic research. The company provides GMP-certified active pharmaceutical ingredients to drug manufacturers worldwide.

Innovation Focus:

• Pharmaceutical-grade retigabine production
• Proprietary synthesis methodologies
• Global distribution network serving 50+ countries

Download FREE Sample Report:
Retigabine Market – View in Detailed Research Report

---

9️⃣ 2. Bio-Techne Corporation

Headquarters: Minneapolis, Minnesota, USA
Key Offering: High-purity Retigabine for research

Through its Tocris Bioscience brand, Bio-Techne supplies retigabine to neuroscience researchers globally, offering comprehensive technical support and validated formulations for experimental protocols.

Innovation Focus:

• GMP and ISO-certified production
• Stable isotope-labeled compounds
• Custom synthesis capabilities

---

8️⃣ 3. Selleck Chemicals

Headquarters: Houston, Texas, USA
Key Offering: Retigabine for preclinical studies

Selleck Chemicals provides retigabine as part of its extensive catalog of bioactive molecules, serving pharmaceutical researchers investigating potassium channel pharmacology.

Innovation Focus:

• High-throughput screening formulations
• Mechanistic study compounds
• Global logistics network

---

7️⃣ 4. Cayman Chemical

Headquarters: Ann Arbor, Michigan, USA
Key Offering: Analytical standards & research compounds

Cayman Chemical specializes in retigabine reference materials and metabolites, supporting pharmaceutical quality control and neurological research applications.

Innovation Focus:

• Certified reference materials
• Impurity standards
• Stability testing solutions

Download FREE Sample Report:
Retigabine Market – View in Detailed Research Report

---

6️⃣ 5. Biosynth Carbosynth

Headquarters: Staad, Switzerland
Key Offering: GMP-grade Retigabine

Biosynth Carbosynth combines chemical expertise with pharmaceutical manufacturing capabilities to supply retigabine for clinical research and potential therapeutic applications.

Innovation Focus:

• Clinical trial materials
• Process development services
• Regulatory documentation support

---

5️⃣ 6. Toronto Research Chemicals

Headquarters: North York, Canada
Key Offering: Certified retigabine standards

TRC supplies high-purity retigabine reference materials to support pharmaceutical analysis and quality assurance processes globally.

Innovation Focus:

• ISO 9001-certified facilities
• Stable isotope-labeled analogs
• Comprehensive analytical data

---

4️⃣ 7. BioVision, Inc.

Headquarters: Milpitas, California, USA
Key Offering: Research-grade retigabine

BioVision provides retigabine formulations for neurological research, with purity levels ranging from 95% to >99% for diverse experimental requirements.

Innovation Focus:

• Structural analogs for SAR studies
• Bulk manufacturing options
• Custom purity specifications

---

3️⃣ 8. Adooq Bioscience

Headquarters: Irvine, California, USA
Key Offering: Small molecule modulators

Adooq Bioscience specializes in potassium channel regulators, offering retigabine in various quantities for neuroscience research and drug discovery programs.

Innovation Focus:

• Mechanistic study formulations
• Bulk API capabilities
• Structure-activity relationship analogs

---

2️⃣ 9. Alomone Labs

Headquarters: Jerusalem, Israel
Key Offering: Ion channel research compounds

Alomone Labs focuses on potassium channel modulators, providing retigabine for electrophysiology studies and neurological research applications.

Innovation Focus:

• Validated cellular assay compounds
• Mechanistic study formulations
• Ion channel-specific applications

---

1️⃣ 10. BOCSCI Inc.

Headquarters: Shirley, New York, USA
Key Offering: Custom retigabine synthesis

BOCSCI provides retigabine to the global research community, with capabilities ranging from milligram to kilogram quantities for pharmaceutical development.

Innovation Focus:

• Structure-activity relationship analogs
• Regulatory support packages
• GMP-scale manufacturing

Get Full Report Here:
Retigabine Market – View in Detailed Research Report

---

🧠 Outlook: The Evolving Landscape of Retigabine Applications

The retigabine market continues to develop as researchers uncover new therapeutic potentials beyond epilepsy treatment. Current investigations explore applications in neuropathic pain, bipolar disorder, and other CNS conditions.

📈 Key Market Trends:

• Growing focus on treatment-resistant epilepsy solutions
• Increasing R&D into retigabine analogs with improved safety
• Expanding academic research into potassium channel modulation
• Advancements in formulation technologies and delivery systems

Get Full Report Here:
Retigabine Market – View in Detailed Research Report

The featured companies are driving scientific progress not only through retigabine supply but also by enabling groundbreaking neurological research that may yield new therapeutic breakthrough.